Staging ovarian carcinoma after surgery and chemotherapy: Radiolabelled monoclonal antibodies and their fragments as an imaging modality

1991 ◽  
Vol 3 ◽  
pp. 295-295
Keyword(s):  
Monoclonal Antibodies ◽  
Ovarian Carcinoma ◽  
Imaging Modality ◽  
Radiolabelled Monoclonal Antibodies

Therapeutic considerations in the use of intraperitoneal radiolabelled monoclonal antibodies in ovarian carcinoma

1989 ◽  
Vol 10 (3) ◽  
pp. 149-159 ◽  
Author(s):  
M. E. CROWTHER ◽  
B. C. WARD ◽  
M. GRANOWSKA ◽  
S. MATHER ◽  
K. E. BRITTON ◽  
...  
Keyword(s):  
Monoclonal Antibodies ◽  
Ovarian Carcinoma ◽  
Radiolabelled Monoclonal Antibodies ◽  
Therapeutic Considerations

Radiolabelled monoclonal antibodies against alpha-fetoprotein for in vivo localization of human hepatocellular carcinoma by immunotomoscintigraphy

1987 ◽  
Vol 13 (8) ◽  
pp. 385-390 ◽  
Author(s):  
Jean-Fran�ois Bergmann ◽  
Jean-Denis Lumbroso ◽  
Luc Manil ◽  
Jean-Claude Saccavini ◽  
Philippe Rougier ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Monoclonal Antibodies ◽  
Alpha Fetoprotein ◽  
Human Hepatocellular Carcinoma ◽  
Radiolabelled Monoclonal Antibodies

A Double Determinant Radioimmunoassay Mov2-Mov8* for Monitoring Ovarian Carcinomas: Definition of the Methodology

1987 ◽  
Vol 2 (3) ◽  
pp. 161-168 ◽  
Author(s):  
Alessandro Diotti ◽  
Olivia Santoro ◽  
Liliana Mantovani ◽  
Mario Regazzoni ◽  
Rosanna Fontanelli ◽  
...  
Keyword(s):  
Monoclonal Antibodies ◽  
Ovarian Carcinoma ◽  
Normal Population ◽  
Ovarian Carcinomas ◽  
Healthy Women ◽  
Circulating Antigens ◽  
Human Ovarian Carcinoma ◽  
Low Levels ◽  
Definition Of ◽  
Apparently Healthy

A double-determinant radioimmunoassay for the detection of circulating antigens associated with human ovarian carcinoma was developed using two monoclonal antibodies: MOv2 and MOv8 employed respectively as catcher and tracer. The development of the method through three different procedures enabled us to detect the presence of CaMOv2-CaMOv8 carrying molecules in 14 out of 15 ascitic fluids from ovarian carcinoma patients whose tumors were found to be positive with MOv2 and MOv8 monoclonal antibodies by immunofluorescence. Moreover, 13 out of 15 ovarian carcinoma patients presented high levels of antigen in their serum (60-170 Ua/ml). Low levels of antigen were observed in the normal population, the values ranging from 30-40 Ua/ml. However, in 13 out of 100 apparently healthy women high levels of antigen were found in the serum

Production of murine monoclonal antibodies against cell-surface antigens of human ovarian carcinoma

1985 ◽  
Vol 30 (4) ◽  
pp. 209-214 ◽  
Author(s):  
Malaya Bhattacharya ◽  
Sunil K. Chatterjee ◽  
Aniruddha Gangopadhyay ◽  
Joseph J. Barlow
Keyword(s):  
Monoclonal Antibodies ◽  
Cell Surface ◽  
Ovarian Carcinoma ◽  
Surface Antigens ◽  
Cell Surface Antigens ◽  
Human Ovarian Carcinoma ◽  
Murine Monoclonal Antibodies

ANTHDIOTYPIC ANTIBODIES AGAINST RADIOLABELLED MONOCLONAL ANTIBODIES IMPROVE RADIOIMMUNOLOCALIZATION AND RADIOIMMUNOTHERAPY

1994 ◽  
Vol 16 (2) ◽  
pp. 159
Author(s):  
T. Stigbrand ◽  
A. Ullén ◽  
B. Nilsson ◽  
K. Riklund-Åhlström ◽  
B. Sundström
Keyword(s):  
Monoclonal Antibodies ◽  
Radiolabelled Monoclonal Antibodies
Sign in / Sign up

Export Citation Format

Share Document